Literature DB >> 6658907

Rapid, transient drop in brain glucose after intravenous phloretin or 3-0-methyl-D-glucose.

W H Oldendorf, P D Crane, P M Lawner, L D Braun.   

Abstract

Rats were injected intravenously with either phloretin (100 mg/kg) or 3-0-methyl glucose (2 g/kg) to reduce the carrier-mediated flux of glucose into brain. Plasma glucose and brain free glucose (BFG), lactate, and glycogen were measured over a 16 min time course. Injection of these substances caused a rapid drop in BFG to 60% of control at one minute and a minimum (50% of control values) at 4 min., followed by a gradual rise to control levels at 16 min. While plasma glucose fell, and then increased after injection, brain lactate and glycogen content was unaffected. Repeated injections of phloretin eventually caused a drop in brain glycogen; but with either competitor, BFG never fell below 50% of normal values. The i.v. injection of the glucose analog, 3-0-methyl glucose (the less toxic of the two drugs) is proposed as a possible means of cutting off the potentially hazardous supply of blood glucose to the postischemic brain.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6658907     DOI: 10.1161/01.str.14.3.388

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  5 in total

1.  Post-oral appetite stimulation by sugars and nonmetabolizable sugar analogs.

Authors:  Steven Zukerman; Karen Ackroff; Anthony Sclafani
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-08-07       Impact factor: 3.619

2.  Pretreatment with 3-O-methyl-D-glucose or 2-deoxy-D-glucose attenuates the post-mortem rise in rat brain lactate.

Authors:  L P Miller; J B Villeneuve; W H Oldendorf
Journal:  Neurochem Res       Date:  1986-04       Impact factor: 3.996

3.  CEST MRI of 3-O-methyl-D-glucose uptake and accumulation in brain tumors.

Authors:  Akansha Ashvani Sehgal; Yuguo Li; Bachchu Lal; Nirbhay N Yadav; Xiang Xu; Jiadi Xu; John Laterra; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2018-09-11       Impact factor: 4.668

4.  Covalent adduct formation between the plasmalogen-derived modification product 2-chlorohexadecanal and phloretin.

Authors:  Andreas Üllen; Christoph Nusshold; Toma Glasnov; Robert Saf; David Cantillo; Gerald Eibinger; Helga Reicher; Günter Fauler; Eva Bernhart; Seth Hallstrom; Nora Kogelnik; Klaus Zangger; C Oliver Kappe; Ernst Malle; Wolfgang Sattler
Journal:  Biochem Pharmacol       Date:  2015-01-06       Impact factor: 5.858

5.  Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain.

Authors:  Y Anraku; H Kuwahara; Y Fukusato; A Mizoguchi; T Ishii; K Nitta; Y Matsumoto; K Toh; K Miyata; S Uchida; K Nishina; K Osada; K Itaka; N Nishiyama; H Mizusawa; T Yamasoba; T Yokota; K Kataoka
Journal:  Nat Commun       Date:  2017-10-17       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.